Business ❯ Pharmaceutical Industry ❯ Drug Development

Market Access

Pricing Strategies Healthcare Economics Cost-Benefit Analysis Generic Drug Production Investment Trends Cost of Medications Funding Initiatives Patient Access Insurance Plans

FDA Outlines 'Plausible-Mechanism' Pathway to Speed Bespoke Therapies

The plan would shift initial proof to small, well-characterized patient cases with real-world follow-up required.

White House Strikes Deals With Lilly and Novo to Cut GLP-1 Prices, Widen Medicare Access

UK and Eli Lilly Unveil £85m Pilot for Pharmacy and Digital Delivery of Weight-Loss Injections

NICE Bars New Alzheimer’s Antibodies from NHS Over Cost and Capacity